Sanofi (Japan)

Basic Information

• Category: business
• Website: http://www.sanofi.co.jp/l/jp/ja/index.jsp

Documented Facts

• Inception (Wikidata): 2004 (Source 5: Wikidata Q30269323, revision 2474208299)
• Country (Wikidata; date unspecified): Japan (Source 5: Wikidata Q30269323, revision 2474208299; Source 6: Wikidata label: Q17, revision 2555599058)
• Official website (Wikidata; date unspecified): http://www.sanofi.co.jp/l/jp/ja/index.jsp (Source 5: Wikidata Q30269323, revision 2474208299)

Evidence and Sources

• Sanofi (Japan) — Official Site (official)
• Sanofi (Japan) on instagram (social)
• Sanofi (Japan) on facebook (social)
• Sanofi (Japan) on linkedin (social)
• Wikidata Q30269323, revision 2474208299 (knowledge-base)
• Wikidata label: Q17, revision 2555599058 (knowledge-base)

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Sanofi (Japan).

• Canonical profile: https://brandsource.ai/brands/sanofi-japan
• Machine-readable JSON-LD: https://brandsource.ai/api/brands/sanofi-japan/json-ld
• Citation profile API: https://brandsource.ai/api/brands/sanofi-japan/citation-profile
• Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
• Data status: Enriched
• Profile completeness: Source-backed profile (91/100)
• Indexing directive: index, follow, max-image-preview:large
• Recorded profile date: 2026-04-22

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

医療関係者の皆さま詳しく見る採用情報詳しく見るマスギャザリングと感染症へFUSEGU2020詳しく見るSanofi Japan Official SNSSanofi Japan Official YouTubeSanofi Japan Official facebookSanofi Japan Official LinkedInSanofi Japan Official Instagramプレスリリースプレスリリースは報道関係者を対象とした、配信時当時の情報を掲載しています。 医療関係者や一般の方々を対象とした医学的な情報提供や、プロモーションが目的のものではありません。 2026年4月16日代表取締役社長人事のお知らせプレスリリースを読む2026年4月15日サノフィのlunsekimig、喘息患者および鼻茸を伴う慢性副鼻腔炎患者を対象とした2つの第II相試験で主要評価項目と主な副次評価項目を達成プレスリリースを読む2026年4月7日サノフィのamlitelimab、アトピー性皮膚炎における第III相試験の新たな結果がAAD2026レイトブレイキングセッションで発表プレスリリースを読む

Available profile information

• Official website is captured for entity disambiguation.
• 1 official source linked for verification.
• 5 supporting sources linked.
• 3 structured facts available for extraction.

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.